Spots Global Cancer Trial Database for Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Official Title: Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

Study ID: NCT02377999

Conditions

Anogenital Warts

Interventions

Picato

Study Description

Brief Summary: An exploratory open label, single treatment trial of anogenital warts with Picato® repeated up to 2 times with two weeks intervals.

Detailed Description: The purpose of the present trial is to explore the safety, tolerability and efficacy when treating GW with Picato® 0.05% gel. The primary outcome measures will be related to safety and tolerability and consists of severity of any local reactions in the treated area; treatment-related adverse events (AEs) and serious AEs.